Sirio Pharma Dividends and Buybacks
Dividend criteria checks 3/6
Sirio Pharma is a dividend paying company with a current yield of 2.12% that is well covered by earnings. Next payment date is on 27th May, 2025 with an ex-dividend date of 27th May, 2025.
Key information
2.1%
Dividend yield
-0.2%
Buyback Yield
| Total Shareholder Yield | 1.9% |
| Future Dividend Yield | 3.1% |
| Dividend Growth | 33.2% |
| Next dividend pay date | 27 May 25 |
| Ex dividend date | 27 May 25 |
| Dividend per share | n/a |
| Payout ratio | 46% |
Recent dividend and buyback updates
Recent updates
Here's Why Sirio Pharma (SZSE:300791) Can Manage Its Debt Responsibly
Mar 13
Sirio Pharma (SZSE:300791) Has Some Way To Go To Become A Multi-Bagger
Feb 24Improved Earnings Required Before Sirio Pharma Co., Ltd. (SZSE:300791) Shares Find Their Feet
Dec 31When Should You Buy Sirio Pharma Co., Ltd. (SZSE:300791)?
Dec 13Is Now The Time To Put Sirio Pharma (SZSE:300791) On Your Watchlist?
Oct 14The Market Lifts Sirio Pharma Co., Ltd. (SZSE:300791) Shares 27% But It Can Do More
Sep 30Is Sirio Pharma (SZSE:300791) Using Too Much Debt?
Sep 23Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares
Aug 01Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around
Jun 30Is Sirio Pharma (SZSE:300791) A Risky Investment?
Jun 12An Intrinsic Calculation For Sirio Pharma Co., Ltd. (SZSE:300791) Suggests It's 24% Undervalued
Apr 24Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly
Mar 06Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300791 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 300791's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Sirio Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300791) | 2.1% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Personal Products) | 1.4% |
| Analyst forecast (300791) (up to 3 years) | 3.1% |
Notable Dividend: 300791's dividend (2.12%) is higher than the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 300791's dividend (2.12%) is low compared to the top 25% of dividend payers in the CN market (2.21%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (45.8%), 300791's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (49.6%), 300791's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 19:52 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sirio Pharma Co., Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jing Huang | Chasing Securities |
| Wendan Wang | China International Capital Corporation Limited |
| Xia Sheng | Citic Securities Co., Ltd. |